Personal information

No personal information available

Activities

Collapse all

Works (12)

Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3

Nature Cell Biology
2024-07 | Journal article
DOI: 10.1038/s41556-024-01446-3
Contributors: Marco Seehawer; Zheqi Li; Jun Nishida; Pierre Foidart; Andrew H. Reiter; Ernesto Rojas-Jimenez; Marie-Anne Goyette; Pengze Yan; Shaunak Raval; Miguel Munoz Gomez et al.
Source: check_circle
Crossref

HER2 heterogeneity and treatment response–associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial

Journal of Clinical Investigation
2024-04-01 | Journal article
DOI: 10.1172/JCI176454
Contributors: Zheqi Li; Otto Metzger Filho; Giuseppe Viale; Patrizia dell’Orto; Leila Russo; Marie-Anne Goyette; Avni Kamat; Denise A. Yardley; Vandana Gupta Abramson; Carlos L. Arteaga et al.
Source: check_circle
Crossref

AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis

Cancers
2022-01-18 | Journal article
DOI: 10.3390/cancers14030466
Contributors: Marie-Anne Goyette; Jean-François Côté
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

CdGAP promotes prostate cancer metastasis by regulating epithelial-to-mesenchymal transition, cell cycle progression, and apoptosis

Communications Biology
2021-09-07 | Journal article
DOI: 10.1038/s42003-021-02520-4
Contributors: Chahat Mehra; Ji-Hyun Chung; Yi He; Mónica Lara-Márquez; Marie-Anne Goyette; Nadia Boufaied; Véronique Barrès; Véronique Ouellet; Karl-Phillippe Guérard; Carine Delliaux et al.
Source: check_circle
Crossref

Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels

Proceedings of the National Academy of Sciences
2021-07-20 | Journal article
DOI: 10.1073/pnas.2023868118
Contributors: Marie-Anne Goyette; Islam E. Elkholi; Chloé Apcher; Hellen Kuasne; Carla V. Rothlin; William J. Muller; Darren E. Richard; Morag Park; Jean-Philippe Gratton; Jean-François Côté
Source: check_circle
Crossref

Biallelic <i>ELMO3</i> mutations and loss of function for DOCK-mediated RAC1 activation result in intellectual disability.

Small GTPases
2021-03-04 | Journal article
DOI: 10.1080/21541248.2021.1888557
PMID: 33660564
Source: Self-asserted source
Marie-Anne Goyette

AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network

Nature Communications
2020-07-17 | Journal article
DOI: 10.1038/s41467-020-17415-x
Contributors: Afnan Abu-Thuraia; Marie-Anne Goyette; Jonathan Boulais; Carine Delliaux; Chloé Apcher; Céline Schott; Rony Chidiac; Halil Bagci; Marie-Pier Thibault; Dominique Davidson et al.
Source: check_circle
Crossref

AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer.

Oncotarget
2019-03-12 | Journal article
DOI: 10.18632/oncotarget.26725
PMID: 31007848
PMC: PMC6459349
Source: Self-asserted source
Marie-Anne Goyette

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression

Cell Reports
2018-05 | Journal article
DOI: 10.1016/j.celrep.2018.04.019
Part of ISSN: 2211-1247
Source: Self-asserted source
Marie-Anne Goyette

The E3 Ubiquitin Ligase HectD1 Suppresses EMT and Metastasis by Targeting the +TIP ACF7 for Degradation

Cell Reports
2018-01 | Journal article
DOI: 10.1016/j.celrep.2017.12.096
Part of ISSN: 2211-1247
Source: Self-asserted source
Marie-Anne Goyette

Nck2 Deficiency in Mice Results in Increased Adiposity Associated With Adipocyte Hypertrophy and Enhanced Adipogenesis.

Diabetes
2016-06-20 | Journal article
DOI: 10.2337/db15-1559
PMID: 27325288
Source: Self-asserted source
Marie-Anne Goyette

NSCLC metastasis: going with ELMO3.

Oncotarget
2014-08-01 | Journal article
DOI: 10.18632/oncotarget.2341
PMID: 25146334
PMC: PMC4171597
Source: Self-asserted source
Marie-Anne Goyette

Peer review (4 reviews for 1 publication/grant)

Review activity for Biomedicine & pharmacotherapy. (4)
How many people are using ORCID?